GPT and Alzheimer disease: Reduced levels of ALT have been associated with reduced brain glucose metabolism, cerebral atrophy, brain amyloid-β deposition, and alterations in neurodegenerative biomarkers concentrations in the cerebrospinal fluid of persons with AD [8].